Li Yonglu, Wang Yadi, Li Yapeng, Yan Shihai, Gao Xin, Li Ping, Zheng Xiaodong, Gu Qing
School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, Zhejiang, People's Republic of China.
Key Laboratory for Food Microbial Technology of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
Crit Rev Food Sci Nutr. 2025;65(16):3149-3172. doi: 10.1080/10408398.2024.2359135. Epub 2024 Jul 15.
Inflammation bowel disease (IBD) has emerged as a public health challenge worldwide; with high incidence and rapid prevalence, it has troubled billions of people and further induced multitudinous systemic complications. Recent decade has witnessed the vigorous application of food-borne probiotics for IBD therapy; however, the complicated and changeable environments of digestive tract have forced probiotics to face multiple pressures, consequently causing unsatisfied prophylactic or therapeutic efficacy attributed to off-targeted arrival, damaged viability, insufficient colonization efficiency, etc. Fortunately, arisen hybrid technology has provided versatile breakthroughs for the targeted transplantation of probiotics. By ingeniously modifying probiotics to form probiotics hybrid systems (PHS), the biological behaviors of probiotics could be mediated, the interactions between probiotics with intestinal components can be facilitated, and diverse advanced probiotic-based therapies for IBD challenge can be developed, which attribute to the intelligent response to microenvironment of PHS, and intelligent design of PHS for multiple functions combination. In this review, various PHS were categorized and their intestinal behaviors were elucidated systematically, their therapeutic effects and intrinsic mechanism were further analyzed. Besides, shortages of present PHS and the corresponding solutions have been discussed, based on which the future perspectives of this field have also been proposed. The undeniable fact is that PHS show an incomparable future to bring the next generation of advanced food science.
炎症性肠病(IBD)已成为全球公共卫生挑战;其发病率高且流行迅速,困扰着数十亿人,并进一步引发众多全身并发症。近十年来,食源益生菌在IBD治疗中得到了广泛应用;然而,消化道复杂多变的环境迫使益生菌面临多种压力,导致因靶向性差、活力受损、定植效率不足等问题而使预防或治疗效果不尽人意。幸运的是,新兴的杂交技术为益生菌的靶向移植提供了多方面的突破。通过巧妙地改造益生菌形成益生菌杂交系统(PHS),可以调节益生菌的生物学行为,促进益生菌与肠道成分之间的相互作用,并开发出针对IBD挑战的多种先进的基于益生菌的疗法,这归因于PHS对微环境的智能响应以及PHS的多功能组合智能设计。在本综述中,对各种PHS进行了分类,并系统地阐明了它们在肠道中的行为,进一步分析了它们的治疗效果和内在机制。此外,还讨论了当前PHS的不足及相应解决方案,并在此基础上提出了该领域的未来展望。不可否认的事实是,PHS展现出无与伦比的未来,将引领下一代先进食品科学。